John Martin Corkery

Biographic Data

ID10441199
NAMEJohn Martin Corkery
GIVEN NAMESJohn Martin
FAMILY NAMECorkery
SIGNATURECORKERY J M
VERIFIEDNo
TOTAL WORKS3
TOTAL CITATIONS0
AUTHOR COUNT3
EDITOR COUNT0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2021
H-INDEX0

  • Identifying New/Emerging Psychoactive Substances at the Time of Covid-19; A Web-Based Approach

    Open AccessValeria Catalani, Davide Arillotta et al.ARTICLEFrontiers in Psychiatry2021

    COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. The aims of the current research were to use a web crawler, NPSfinder®, to identify and categorize emerging NPS discussed on a range of drug enthusiasts/psychonauts' websites/fora at the time of the pandemic…

  • Covid-19

    Open AccessStefania Chiappini, Amira Guirguis et al.ARTICLEFrontiers in Psychiatry2020

    © 2020 Chiappini, Guirguis, John, Corkery and Schifano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY - https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academi…

  • The Psychonauts’ World of Cognitive Enhancers

    Open AccessFlavia Napoletano, Fabrizio Schifano et al.ARTICLEFrontiers in Psychiatry2020

    These results show that NPSfinder ® is helpful as part of an Early Warning System, which could update clinicians with the growing numbers and types of nootropics in the increasingly difficult-to-follow internet world. Improving clinicians' knowledge of NPS could promote more effective prevention and harm reduction measures in clinical settings